Literature DB >> 4571160

Chemical structure and teratogenic properties. 3. A review of available data on structure-activity relationships and mechanism of action of thalidomide analogues.

N A Jönsson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4571160

Source DB:  PubMed          Journal:  Acta Pharm Suec        ISSN: 0001-6675


× No keyword cloud information.
  5 in total

Review 1.  Thalidomide-type teratogenicity: structure-activity relationships for congeners.

Authors:  R L Smith; S C Mitchell
Journal:  Toxicol Res (Camb)       Date:  2018-09-26       Impact factor: 3.524

Review 2.  Thalidomide in cancer treatment: a potential role in the elderly?

Authors:  Shufeng Zhou; Philip Kestell; Malcolm D Tingle; James W Paxton
Journal:  Drugs Aging       Date:  2002       Impact factor: 3.923

Review 3.  Current status of thalidomide and CC-5013 in the treatment of metastatic prostate cancer.

Authors:  Tristan M Sissung; Silja Thordardottir; Erin R Gardner; William D Figg
Journal:  Anticancer Agents Med Chem       Date:  2009-12       Impact factor: 2.505

4.  Thalidomide teratogenesis: evidence for a toxic arene oxide metabolite.

Authors:  G B Gordon; S P Spielberg; D A Blake; V Balasubramanian
Journal:  Proc Natl Acad Sci U S A       Date:  1981-04       Impact factor: 11.205

5.  Structural basis of thalidomide enantiomer binding to cereblon.

Authors:  Tomoyuki Mori; Takumi Ito; Shujie Liu; Hideki Ando; Satoshi Sakamoto; Yuki Yamaguchi; Etsuko Tokunaga; Norio Shibata; Hiroshi Handa; Toshio Hakoshima
Journal:  Sci Rep       Date:  2018-01-22       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.